COVID-19 has changed the world during the past couple of years, and one of its lasting legacies will be the need for speed and agility in all spheres of healthc 22 August 2022
The outbreak of coronavirus disease (COVID-19) has brought the issue of localization to the forefront, which necessitated the need for localization of pharmaceu 8 August 2022
Amicus Therapeutics chairman and chief executive John Crowley and the company's general manager for the UK and Ireland.Charlie Galvin.provide an Expert View on 28 July 2022
For years, commentators have observed that drug prices in the USA are significantly higher than elsewhere in the world. As the US Congress debates government ac 22 July 2022
One year on from the historic approval of the first new Alzheimer’s med in decades, the world’s largest event focused on the disease is set to take place in San 22 July 2022
Life science companies look to technology solution to increase efficiencies and reduce errors, whether these are related to data entry or other reasons. 18 July 2022
USA-based Insmed (NASDAQ CM: INSM) is a biopharmaceutical company on the development and commercialization of novel, targeted inhaled therapies for patients with serious rare diseases.
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news